(Q81748326)
Statements
[Indications for use of labile blood products and the physiology of blood transfusion in medicine. The French Agency for the Health Safety of Health Products] (English)
H Gouëzec
P Jego
Pierre Bétrémieux
Stanislas Nimubona
Isabelle Grulois
1 reference
1 reference